Intellia Therapeutics, Inc.NTLANASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank91
5Y CAGR+64.5%
Year-over-Year Change
Net other income and expenses outside core operations
5Y CAGR
+64.5%/yr
Long-term compound
Percentile
P91
Near historical high
vs 5Y Ago
12x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $28.30M | +85.6% |
| 2024 | $15.24M | -55.3% |
| 2023 | $34.10M | +312.8% |
| 2022 | $-16.02M | -38047.6% |
| 2021 | $-42000.00 | -101.8% |
| 2020 | $2.35M | -65.6% |
| 2019 | $6.83M | +23.7% |
| 2018 | $5.53M | +174.7% |
| 2017 | $2.01M | +283.2% |
| 2016 | $525000.00 | - |